Phase 2 Basket Study of Tucatinib in Combination with Trastuzumab in Subjects with Previously Treated, Locally-Advanced Unresectable or Metastatic Solid Tumors Driven by HER2 Alterations
Clinical Trial Grant
Awarded By
Seattle Genetics, Inc
Start Date
September 1, 2020
End Date
September 2, 2025
Awarded By
Seattle Genetics, Inc
Start Date
September 1, 2020
End Date
September 2, 2025